These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11223892)

  • 21. Dilantin jeopardy: avoiding the dangers of phenytoin.
    Schlicher ML
    Medsurg Nurs; 1998 Dec; 7(6):343-7, 356. PubMed ID: 10036438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of prenatal exposure to anticonvulsant drugs on dermal ridge patterns of fingers.
    Bokhari A; Coull BA; Holmes LB
    Teratology; 2002 Jul; 66(1):19-23. PubMed ID: 12115776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum IgA deficiency induced by prolonged phenytoin treatment.
    Talesnik E; Rivero SJ; González B
    Rev Invest Clin; 1989; 41(4):331-5. PubMed ID: 2631168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemostasis in epileptic patients treated with anticonvulsant drugs].
    de Pasquet EG; Ghiggino CW; Toledo S; Tenzer SM
    Acta Neurol Latinoam; 1973; 19(1-4):67-77. PubMed ID: 4808368
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydantoin immunosuppression clinical study.
    Badawy AH; Shalaby SA; Abdel Aal SF
    J Egypt Soc Parasitol; 1991 Apr; 21(1):257-62. PubMed ID: 2033299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum phenytoin concentration and IgG antibody titre to periodontal bacteria in patients with phenytoin-induced gingival overgrowth.
    Yamada H; Nishimura F; Furuno K; Naruishi K; Kobayashi Y; Takashiba S; Murayama Y
    J Int Acad Periodontol; 2001 Apr; 3(2):42-7. PubMed ID: 12666977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of phenytoin induced gingival overgrowth in epileptic children: a six month evaluation.
    Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
    J Indian Soc Pedod Prev Dent; 2002 Jun; 20(2):73-80. PubMed ID: 12435021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose.
    Su CM; Kung CT; Wang YC; Lu CH
    Neurol India; 2009; 57(2):200-2. PubMed ID: 19439856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy.
    Chiyonobu T; Noda R; Yoshida M; Fujiki A; Ishii R; Nukina S; Fujita K; Goto Y; Morimoto M
    Brain Dev; 2008 Jun; 30(6):430-3. PubMed ID: 18226864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sister-chromatid exchange, chromosomal aberrations and delays in cell-cycle kinetics in human lymphocytes induced by dental composite resin eluates.
    Bakopoulou A; Mourelatos D; Tsiftsoglou AS; Mioglou E; Garefis P
    Mutat Res; 2008 Jan; 649(1-2):79-90. PubMed ID: 17950025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid and phenytoin induced gingival overgrowth--is there a preventive effect.
    Prasad VN; Chawla HS; Goyal A; Gauba K; Singhi P
    J Indian Soc Pedod Prev Dent; 2004 Jun; 22(2):82-91. PubMed ID: 15491092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenytoin toxicity: an easily missed cause of cerebellar syndrome.
    Brostoff JM; Birns J; McCrea D
    J Clin Pharm Ther; 2008 Apr; 33(2):211-4. PubMed ID: 18315788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting antiepileptic drug pharmacokinetics in community-dwelling elderly.
    Cloyd JC; Marino S; Birnbaum AK
    Int Rev Neurobiol; 2007; 81():201-10. PubMed ID: 17433925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum anticonvulsant levels in therapy-resistant epileptics].
    Broeker H; Müller D; Müller J; Walther H
    Psychiatr Neurol Med Psychol (Leipz); 1980 Sep; 32(9):541-9. PubMed ID: 6777793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation kinetics and genotoxicity in lymphocytes of smokers living in Mexico City.
    Calderón-Ezquerro C; Sánchez-Reyes A; Sansores RH; Villalobos-Pietrini R; Amador-Muñoz O; Guerrero-Guerra C; Calderón-Segura ME; Uribe-Hernández R; Gómez-Arroyo S
    Hum Exp Toxicol; 2007 Sep; 26(9):715-22. PubMed ID: 17984142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of sister chromatid exchange induction in phenytoin-treated patients with epilepsy.
    Schaumann BA; Winge VB; Garry VF
    Epilepsia; 1989; 30(2):240-5. PubMed ID: 2924749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenytoin as the first option in female epileptic patients?
    Trevisol-Bittencourt PC; da Silva VR; Molinari MA; Troiano AR
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):784-6. PubMed ID: 10751912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.